Suppr超能文献

硫唑嘌呤联合类固醇治疗自身免疫性内耳疾病。

Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease.

作者信息

Saraçaydin A, Katircioglu S, Katircioglu S, Karatay M C

机构信息

Department of Otorhinolaryngology, Istanbul University Faculty School of Medicine, Turkey.

出版信息

J Int Med Res. 1993 Jul-Aug;21(4):192-6. doi: 10.1177/030006059302100404.

Abstract

A total of twelve patients with a relatively uncommon form of progressive sensorineural deafness (autoimmune inner-ear disease) were treated orally with 1 mg/kg azathioprine, once daily, and with 30 mg prednisolone, every other day, for 4 weeks. Statistically significant increases in the ability to hear pure tones or in discrimination on audiometry took place in 10/12 patients. This condition was initially described as 'sensorineural hearing loss', but it is now clear that the term 'autoimmune inner-ear disease' is more appropriate since the vestibular compartment as well as the cochlear compartment is involved. This relatively uncommon disease is one of the few forms of sensorineural deafness that can be successfully treated.

摘要

共有12例患有相对罕见的进行性感音神经性耳聋(自身免疫性内耳疾病)的患者接受了治疗,口服硫唑嘌呤,剂量为1毫克/千克,每日一次,同时口服泼尼松龙,剂量为30毫克,隔日一次,持续4周。12例患者中有10例在纯音听力或听力测定辨别能力方面出现了具有统计学意义的提高。这种病症最初被描述为“感音神经性听力损失”,但现在很清楚,“自身免疫性内耳疾病”这个术语更合适,因为前庭腔和耳蜗腔都受到了影响。这种相对罕见的疾病是少数几种能够成功治疗的感音神经性耳聋形式之一。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验